Dorea sp.

Information

Microbe Identification

Dorea sp.

Microbe id: PMDBM2021511
Level: Species
NCBI Taxonomy ID:
Taxonomy Species: Dorea sp. [2040332]
Taxonomy Genus: Dorea [189330]
Taxonomy Family: Lachnospiraceae [186803]

Interactions between microbe and active substances


ⓘ How do we work out MGCs and BGCs of one specific species?


Metabolic gene clusters of Dorea sp.

No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View gutSMASH Detailed Result
Biosynthetic gene clusters of Dorea sp.


No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View antiSMASH Detailed Result
Map of Dorea sp. distribution in human body and influence of diseases distribution in human body and influence of diseases


ⓘ How do you use the microbe distribution map?
ⓘ How did we get the relative abundance and microbe change in the map?
bodymap Oral Nose Esophagus Stomach Trachea Upper respiratory tract Vagina Blood Urethral Lung Cervix Rectum Skin Duodenum Fallopian tube Fallopian tube Peritoneal fluid Uterus Ear Ovary Ovary Colon Ileum Cecum
Disease id Bodysite Relative abundance (%) Disease name Microbe_change

Relative abundance landscape of Dorea sp. in human gut microbiota samples



Abundance lanscape in healthy samples (by patients' age)
Abundance lanscape in healthy samples (by patients' country)
Abundance lanscape in disease samples
⚠ About the relative abundance profile

The relative taxonomical abundance data (pre-processed using a unified analysis pipeline) was retrieved from curatedMetagenomicData resource [Edoardo Pasolli, et al. Nat Methods. 2017;14(11):1023-1024]. Data retrieved here was pre-processed as unified relative abundance: at each taxonomic level (e.g., species, genus, family), the sum of microbial abundance of individual microbiota sample was 1, and relative abundance of each microbe was log10 transformed [relative abundance ranges from -7 to 0].

Healthy samples and disease samples (only disease types with >= 20 samples were included) were grouped by age periods, patients?country, or disease type to plot the relative abundance landscape using ggplot2 R package.



Comparative analysis of human gut metagenomes between disease and healthy samples of Dorea sp.

Data source: Phenotype comparisons were obtained from GMrepo . We summarized all comparisons that included healthy samples as controls and overlapped with microbes represented in MASI.

Note: LDA scores below 0 indicate taxa enriched in healthy samples, whereas scores above 0 indicate taxa enriched in disease samples.

Disease Project ID LDA score Experiment Type
Kidney Failure, Chronic PRJEB65297🔗-3.79419333936064mNGS
Kidney Failure, Chronic PRJNA449784🔗-3.4092796916892mNGS
Kidney Failure, Chronic PRJNA648014🔗-3.2721472398723816S
Hemangioma, Cavernous PRJNA629755🔗-3.70641225587062mNGS
Hypertension PRJNA509999🔗-3.76366946232017mNGS
Depression, Postpartum PRJNA637228🔗-4.5201495321966616S
Arthritis, Juvenile PRJNA562467🔗-3.4181027397110416S
Liver Cirrhosis, Alcoholic PRJNA690835🔗-4.1243687122241216S
Diarrhea PRJNA317326🔗-4.062326820316216S
Diarrhea PRJEB14038🔗-3.63879368037692mNGS
Dwarfism PRJNA819198🔗-3.7198735687454616S
Colorectal Neoplasms PRJNA284542🔗-3.8547427854235216S
Colorectal Neoplasms PRJEB46665🔗-3.7654363366371716S
Colorectal Neoplasms PRJNA731589🔗-3.67457835016075mNGS
Colorectal Neoplasms PRJNA1167935🔗-3.38429659276805mNGS
Colorectal Neoplasms PRJNA888860🔗-3.24731164524057mNGS
Respiratory Syncytial Virus Infections PRJNA579491🔗-3.0826097873729316S
Tuberculosis PRJNA795263🔗-4.1241442634877716S
Mental Disorders PRJNA278793🔗-3.0094302708025216S
Colitis, Ulcerative PRJNA804422🔗-3.9582469550332516S
Colitis, Ulcerative PRJNA993675🔗-3.71542228130045mNGS
Colitis, Ulcerative PRJNA398089🔗3.04013588402762mNGS
Spinal Cord Injuries PRJNA669472🔗-4.1572309968282516S
Spinal Cord Injuries PRJNA861246🔗-3.8956567884074216S
Carcinoma, Renal Cell PRJNA842560🔗3.5821637342977616S
Carcinoma, Hepatocellular PRJNA932948🔗-3.77712588406339mNGS
Metabolic Syndrome PRJNA417579🔗3.7013031317425816S
Caliciviridae Infections PRJNA788674🔗-4.2906731687933416S
Lymphoma, Large B-Cell, Diffuse PRJNA906033🔗-3.3911203070284216S
Hidradenitis Suppurativa PRJEB43835🔗-4.0977310029238516S
Asthma PRJEB23348🔗-3.7174682815026616S
Crohn Disease PRJNA917086🔗-4.228282984964816S
Crohn Disease PRJNA938107🔗-4.0752263214280116S
Crohn Disease PRJNA909073🔗-4.0596010919542716S
Crohn Disease PRJNA1156939🔗-3.7109245394718116S
Crohn Disease PRJNA993675🔗-3.67781798476045mNGS
Crohn Disease PRJNA793776🔗-3.47374889045999mNGS
Crohn Disease PRJNA398089🔗2.54408799726464mNGS
Polycystic Ovary Syndrome PRJEB38647🔗-3.3887273565409816S
Purpura, Thrombocytopenic, Idiopathic PRJNA858062🔗2.89455357784787mNGS
Cholestasis PRJNA478781🔗3.4189618774988716S
Moyamoya Disease PRJNA917033🔗3.482534089309416S
Meningioma PRJNA626591🔗-4.1444187267731716S
Fatigue Syndrome, Chronic PRJNA379741🔗-3.10286040986765mNGS
Fatigue Syndrome, Chronic PRJNA751448🔗-3.08603033004858mNGS
Fatigue Syndrome, Chronic PRJNA878603🔗-2.96009790205439mNGS
Autoimmune Diseases of the Nervous System PRJNA586763🔗3.8699035552248316S
Alopecia Areata PRJEB32557🔗3.7867264573087116S
Cholangiocarcinoma PRJNA932948🔗-3.73356034647413mNGS
Anorexia Nervosa PRJEB38930🔗-3.3274111576124216S
Hepatitis C PRJNA1070593🔗-3.8491621904226916S
Neuroblastoma PRJEB63351🔗-3.5253465051813mNGS
Hematologic Neoplasms PRJNA777832🔗-3.9979013031602916S
Peutz-Jeghers Syndrome PRJNA905444🔗-3.36941655825497mNGS
Peutz-Jeghers Syndrome PRJNA545597🔗3.097687964203416S
Clostridium Infections PRJNA648321🔗-4.08952204243995mNGS
Pancreatic Neoplasms PRJNA665854🔗-4.43865229201552mNGS
Alzheimer Disease PRJNA770746🔗-3.2957478110314616S
Lung Neoplasms PRJNA507734🔗-3.9529327533066516S
Lung Neoplasms PRJNA736821🔗-3.6554562580449516S
Glomerulonephritis, IGA PRJNA785415🔗-3.9416228465191316S
Liver Cirrhosis PRJNA861246🔗-3.9106357197118316S
Obesity PRJNA1125836🔗4.0040367837643mNGS
HIV Infections PRJNA810567🔗-3.8762123766355916S
Autism Spectrum Disorder PRJNA686821🔗-3.53250408005627mNGS
Inflammatory Bowel Diseases PRJNA511372🔗-4.72937383783014mNGS
Renal Insufficiency, Chronic PRJNA949558🔗4.0870810865625816S
Fibromyalgia PRJEB80379🔗-4.28574251178541mNGS
Breast Neoplasms PRJNA383849🔗-3.5809271196821816S
Breast Neoplasms PRJNA658160🔗-2.6300728513884616S
COVID-19 PRJNA624223🔗-4.52113667034654mNGS
COVID-19 PRJNA678695🔗-3.9471052206909716S
COVID-19 PRJDB13214🔗-3.90610864442337mNGS
COVID-19 PRJNA689961🔗-3.82085740804304mNGS
COVID-19 PRJNA907010🔗4.1770563993063516S
COVID-19 PRJNA769052🔗4.1837894334213916S
Sepsis PRJNA641414🔗-3.0806073505385216S

Microbe-Therapeutic Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of therapeutic substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of therapeutic substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Therapeutic substance that metabolized by Dorea sp.



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Therapeutic Substances that affect the Dorea sp.



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)


Drug involved metabolizing or transporting reactions that are carried out by Dorea sp.

No data available!

ⓘ How do we get these drug reactions?

To obtain the reactions associated with therapeutic substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331] database.
Identifying Drug-Associated Reactions: Next, we extracted all reactions that are linked to therapeutic substances from these reconstructions. This involved filtering and identifying reactions specifically related to drug metabolism and transport.
Linking Reaction to Microbes: Utilizing the identified reaction related genes (UidA, Tdc etc.), we machted the corresponding drug-associated reactions to existing microbes in the reconstructions in AGORA2. We could link the presence of these genes in different microbes to the potential for those microbes to carry out the corresponding drug-related reactions.
Putative Drug Reactions: As a result, the drug reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with therapeutic substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGORA2)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGORA2, allowing access to the original .mat files. For more details, visit the AGORA2 repository.

# Model Download
No records found

Detailed Information of drug reactions

Metabolism
Transport
Drug Substrate Drug Metabolite Gene responsible for the reaction Reaction Description Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Substance Name Gene responsible for the reaction Reaction Description Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Herbal Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of herbal substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of herbal substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Traditional medicines/herbs/herbal compounds that metabolized by Dorea sp.


Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Traditional medicines/herbs/herbal compounds that affect the Dorea sp.



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)

Microbe-Dietary Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of dietary substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of dietary substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGREDA [Ref:Nature Communications, 12 (2021) 4728]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Dietary Substances alter the abundance of Dorea sp.

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)





Dietary substance that metabolized by Dorea sp.

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)




Dietary Substance involved metabolizing or transporting reactions that are carried out by Dorea sp.

ⓘ How do we get these diet reactions?

To obtain the reactions associated with dietary substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGREDA [Ref:Nature Communications, 12 (2021) 4728] database.
Identifying Diet-Associated Reactions: Next, we extracted all reactions that are linked to dietary substances from these reconstructions. This involved filtering and identifying reactions specifically related to dietary substance metabolism and transport.
Linking Reactions to Microbes: Using the identified related genes (e.g., UidA, Tdc) for each drug metabolite reaction, we matched these reactions to microbes possessing the corresponding genes. This allowed us to link the presence of these genes in different microbes to their potential for carrying out the associated drug-related reactions.
Putative Drug Reactions: As a result, the diet reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with dietary substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGREDA)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGREDA, allowing access to the original .xml files. For more details, visit the AGREDA repository.

# Model View
No records found

Detailed Information of diet reactions

Metabolism
Transport
Diet Substrate Enzyme Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Dietary Substance Name Reaction Name Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Environmental Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of environmental substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of environmental substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Environmental Substances that metabolized by Dorea sp.



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Environmental Substances that affect the Dorea sp.


Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)
ⓘ Background And User Guideline

Microbe Taxonomy level Species Quorum Sensing (QS) Language QS Language Class Total No. of QS Languages of the Species Reference (PubMed ID)


Diseases associated with the microbe Dorea sp.


No data available

Microbiota Site Disease Name Disease Association Class Disease Associated Abundence Change Reference (PubMed ID)



Landscape of Bacteria-Substance-Disease Interaction/Association Network



ⓘ How is the network built?